Welcome to
On Feet Nation
Roots Analysis is pleased to announce the publication of its recent study, titled, “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest…
ContinueAdded by Kevin Doe on January 6, 2022 at 5:07pm — No Comments
Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing
Roots Analysis is pleased to announce the publication of its recent study, titled, “Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030.”
The report features an extensive study of the current market landscape and…
ContinueAdded by Kevin Doe on September 21, 2021 at 6:07am — No Comments
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption…
ContinueAdded by Kevin Doe on July 30, 2021 at 3:12pm — No Comments
Roots Analysis has announced the addition of “Global Antibody Purification Services Market, 2021 – 2030” report to its list of offerings.
Isolation and purification of antibodies, from different sources, including serum, ascites fluid and hybridoma cell culture, requires specialized equipment and focused expertise; as a result, drug developers and academic institutions outsource various aspects of downstream processing, including antibody purification to contract service providers,…
ContinueAdded by Kevin Doe on July 25, 2021 at 3:01pm — No Comments
London
Roots Analysis has announced the addition of “Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices” report to its list of offerings.
The wide-spread prevalence of chronic diseases has compelled drug developers to innovate and design better, more advanced healthcare solutions. Large volume wearable injectors were developed to specifically address certain challenges associated with the administration of high…
ContinueAdded by Kevin Doe on May 25, 2021 at 1:23pm — No Comments
Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the…
ContinueAdded by Kevin Doe on May 25, 2021 at 1:21pm — No Comments
To order this detailed 285+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
Key Inclusions
A detailed review of the overall landscape of companies, offering contract services for the manufacturing of antibodies, along with information on year of establishment, company size, scale of operation (preclinical, clinical and…
Added by Kevin Doe on May 6, 2021 at 3:45am — No Comments
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a myriad of diseases, they are generally associated with high costs of development and complex manufacturing protocols; this is true for antibody-based products as well. Presently, there are a number of companies that claim to offer end-to-end solutions, ranging from antibody development to commercial production. Further, prevalent trends suggest that sponsor companies are likely to…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:45am — No Comments
Roots Analysis has done a detailed study on Antibody Contract Manufacturing Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 285+ page report, which features 100+ figures and 110+ tables, please visit this -https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
Key Market…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:44am — No Comments
The benefits of engaging a CMO or CDMO for antibody development and production extend beyond fulfilling the needs of small companies; access to new technologies and operational flexibility are attractive attributes to larger players as well
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.
The report features an extensive study of the current market landscape…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:44am — No Comments
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings.
Although biopharmaceuticals offer significant profit margins and have been proven to be effective in treating a…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:43am — No Comments
To order this detailed 370+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Key Inclusions
A detailed review of the overall landscape of bispecific antibody therapeutics, including information on drug developers, phase of development (marketed, clinical, and preclinical / discovery) of the pipeline candidates,…
Added by Kevin Doe on May 6, 2021 at 3:42am — No Comments
With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.
To order this 370+ page report, which features 90+ figures and 110+ tables, please…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:41am — No Comments
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this -…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:40am — No Comments
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community
Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”
The report features an extensive study of the current market landscape, offering an…
ContinueAdded by Kevin Doe on May 6, 2021 at 3:40am — No Comments
Roots Analysis has done a detailed study on Virtual Clinical Trial Service Providers Market, 2020-2050, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 280+ page report, which features 180+ figures and 230+ tables, please visit this link
Key Market Insights
Currently, many companies claim to have advanced technology platforms, which enable them to decentralize the clinical research process, thereby,…
Added by Kevin Doe on May 4, 2021 at 1:22pm — No Comments
Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Virtual Clinical Trial Service Providers Market, 2020-2050”
The report features an extensive study of the current landscape of industry players that are…
ContinueAdded by Kevin Doe on May 4, 2021 at 1:21pm — No Comments
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene therapies pipeline is growing, and the market anticipated to witness substantial growth, till 2030
Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to its list of offerings.
Success of approved gene therapies has resulted in a surge in interest of biopharmaceutical developers…
ContinueAdded by Kevin Doe on May 4, 2021 at 1:21pm — No Comments
Given their potential to treat rare, inherited diseases, as well as those previously deemed incurable, the field of gene therapy has gained significant traction in the last few years
Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.
The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral…
ContinueAdded by Kevin Doe on May 4, 2021 at 1:20pm — No Comments
To order this detailed 380+ page report, please visit this -https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html
Key Inclusions
A detailed assessment of the current market landscape of psychedelic therapeutics, providing information on phase of development (commercial, clinical, preclinical, and discovery stage) of lead candidates, type of psychedelic…
Added by Kevin Doe on May 3, 2021 at 11:25am — No Comments
© 2024 Created by PH the vintage. Powered by